U015 Neonatal Inpatient Consults
DESCRIPTION
This session will review a variety of benign and serious neonatal skin conditions seen in the neonatal intensive care unit or nursery. Diagnostic and management strategies will be discussed. The important role that a dermatologist plays in the team caring for the patient will be reviewed.
LEARNING OBJECTIVES
Formulate a differential diagnosis for more benign and serious neonatal skin conditions.
Recognize clinical clues and identify bedside diagnostic tests and other testing that can help make the diagnosis.
Select the most appropriate management strategies for the hospitalized neonate.
SCHEDULE
4:30 PM
Neonatal Inpatient Consults
DIRECTOR
Lucia Zoraida Diaz, MD, FAAD
SPEAKERS
Smita Awasthi, MD, FAAD
Colleen Cotton, MD, FAAD
Catalina Matiz, MD, FAAD
DISCLOSURES
Smita Awasthi, MD, FAAD
Pfizer Inc. – Investigator(No Compensation Received);
Colleen Cotton, MD, FAAD
Amgen – Investigator(Grants/Research Funding); CorEvitas – Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); HS Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Inner Archways LLC – Advisory Board(Other Financial Benefit); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding);
Lucia Zoraida Diaz, MD, FAAD
Incyte – Investigator(No Compensation Received); Regeneron – Investigator(No Compensation Received); UpToDate, Inc – Other(Honoraria);
Catalina Matiz, MD, FAAD
No financial relationships exist with ineligible companies.